Alexander T Cohen Selected Research

betrixaban

6/2020	Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom.
2/2020	Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.
12/2019	Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.
10/2019	Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis.
4/2019	Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.
1/2019	Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States.
1/2019	Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
1/2018	Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.
1/2018	Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.
1/2018	Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander T Cohen Research Topics

Disease

101	Venous Thromboembolism 10/2022 - 03/2002
73	Hemorrhage 10/2022 - 08/2004
30	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 11/2002
27	Pulmonary Embolism 01/2022 - 01/2005
26	Neoplasms (Cancer) 01/2022 - 03/2002
17	Thrombosis (Thrombus) 01/2022 - 03/2002
9	Stroke (Strokes) 01/2020 - 03/2009
5	Body Weight (Weight, Body) 08/2021 - 09/2016
4	Obesity 08/2021 - 02/2005
4	Atrial Fibrillation 02/2021 - 01/2018
4	Thromboembolism 11/2016 - 01/2005
3	Heart Failure 11/2017 - 06/2003
3	Myocardial Infarction 05/2014 - 07/2009
2	Embolism (Embolus) 10/2022 - 05/2015
2	Renal Insufficiency (Renal Failure) 01/2019 - 03/2017
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Ischemic Stroke 01/2017 - 05/2014
2	Varicose Veins (Varicose Vein) 04/2016 - 02/2005
2	Infections 04/2012 - 06/2003
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2010 - 07/2009
1	Chronic Renal Insufficiency 06/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2022
1	Phlebitis 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Hepatic Infarction 01/2022
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2022
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2021
1	Thrombotic Microangiopathies 08/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2021
1	Hematoma 01/2021
1	Cerebral Hemorrhage 01/2021
1	Lung Diseases (Lung Disease) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Dementia (Dementias) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019
1	Frailty 11/2018
1	Multiple Myeloma 10/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Nausea 01/2018

Drug/Important Bio-Agent (IBA)

46	AnticoagulantsIBA 06/2022 - 01/2006
35	Enoxaparin (Lovenox)FDA LinkGeneric 10/2022 - 03/2002
25	RivaroxabanIBA 10/2022 - 06/2012
25	apixabanIBA 06/2022 - 02/2014
24	Warfarin (Coumadin)FDA LinkGeneric 06/2022 - 11/2002
22	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 11/2002
20	betrixabanIBA 06/2020 - 03/2014
19	Vitamin K FDA Link 07/2020 - 07/2010
15	edoxabanIBA 01/2022 - 09/2010
13	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 02/2008
9	fibrin fragment D (D-dimer)IBA 01/2019 - 05/2004
7	Pharmaceutical PreparationsIBA 10/2022 - 09/2013
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 01/2006
7	Factor Xa InhibitorsIBA 01/2019 - 01/2016
5	Dalteparin (Dalteparin Sodium)FDA Link 01/2022 - 08/2004
5	Dabigatran FDA Link 07/2020 - 06/2012
5	Fondaparinux (Arixtra)FDA Link 06/2020 - 02/2006
4	Factor Xa (Coagulation Factor Xa)IBA 01/2019 - 01/2016
3	PRT064445IBA 04/2022 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2015
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 09/2016
3	ORALIT (ORS)IBA 01/2018 - 10/2017
3	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 09/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2017 - 09/2016
3	melagatranIBA 01/2006 - 02/2003
3	ximelagatran (Exanta)IBA 01/2006 - 02/2003
2	CreatinineIBA 07/2020 - 09/2016
2	C-Reactive ProteinIBA 01/2019 - 11/2017
2	A-factor (Streptomyces)IBA 01/2019 - 01/2016
2	cupric sulfide (CuS)IBA 12/2018 - 01/2018
2	AntithrombinsIBA 01/2006 - 02/2003
2	enoxaparin sodium FDA LinkGeneric 01/2005 - 05/2004
1	Prothrombin (Factor II)IBA 04/2022
1	2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA 01/2022
1	COVID-19 VaccinesIBA 08/2021
1	VaccinesIBA 08/2021
1	Antineoplastic Agents (Antineoplastics)IBA 05/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	AlbuminsIBA 01/2019
1	Immunomodulating AgentsIBA 10/2018
1	AntiemeticsIBA 01/2018
1	hemoglobin ASIBA 01/2018

Therapy/Procedure

35	Therapeutics 04/2022 - 07/2010
6	Secondary Prevention 12/2019 - 03/2009
4	Drug Therapy (Chemotherapy) 06/2021 - 02/2011
4	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2010 - 11/2002
2	Bridge Therapy 01/2020 - 11/2018
2	Operative Surgical Procedures 01/2020 - 02/2011
2	Length of Stay 01/2016 - 12/2015
2	Orthopedic Procedures 01/2006 - 11/2002
1	Catheters 12/2021
1	Oral Administration 02/2021
1	Anticoagulation Reversal 01/2021
1	Time-to-Treatment 01/2021
1	Polypharmacy 01/2018